FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964499056> ?p ?o ?g. }

• W1964499056 endingPage "471" @default.
• W1964499056 startingPage "468" @default.
• W1964499056 abstract "To report the clinical outcome and complications of intravitreal injections of crystalline cortisone in patients undergoing pars plana vitrectomy for treatment of proliferative diabetic retinopathy.The prospective, interventional case series study included 29 consecutive patients (29 eyes) who underwent pars plana vitrectomy for treatment of complicated proliferative diabetic retinopathy associated with central retinal traction detachment. All patients received an intravitreal injection of 15 to 20 mg of crystalline triamcinolone acetonide at the end of surgery, and were operated on by the same surgeon. Mean follow-up time was 1.4 +/- 1.1 months (median, 1 month; range, 0.30 to 4.9 months).At the end of the follow-up period, the retina was attached in 26 of the 29 patients (89.7%). In three of the 29 patients (10.3%), a retinal redetachment had occurred. None of the patients developed iris neovascularization, and the iris neovascularization, present preoperatively in 12 patients, slightly to markedly regressed in all 12 patients. Preoperative and postoperative intraocular pressure values (P =.72) and blood glucose measurements did not vary significantly. A pseudohypopyon consisting of cortisone crystals in the inferior anterior chamber angle was detected in one patient and resolved spontaneously within 4 days.The present clinical study suggests that intravitreal injection of crystalline cortisone with most of the vehicle removed seems to be well tolerated by eyes undergoing pars plana vitrectomy for treatment of complicated diabetic proliferative retinopathy. In view of the antiphlogistic and antiproliferative effect of cortisone, future randomized clinical trials may be indicated to investigate further the role of intravitreal injection of crystalline cortisone in the treatment of proliferative diabetic retinopathy." @default.
• W1964499056 created "2016-06-24" @default.
• W1964499056 creator A5048478429 @default.
• W1964499056 creator A5082561940 @default.
• W1964499056 creator A5084778625 @default.
• W1964499056 creator A5090104091 @default.
• W1964499056 date "2001-04-01" @default.
• W1964499056 modified "2023-10-16" @default.
• W1964499056 title "Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy" @default.
• W1964499056 cites W124762270 @default.
• W1964499056 cites W1966539434 @default.
• W1964499056 cites W1976067883 @default.
• W1964499056 cites W1976909570 @default.
• W1964499056 cites W1977790296 @default.
• W1964499056 cites W1988792595 @default.
• W1964499056 cites W1996686941 @default.
• W1964499056 cites W1996949783 @default.
• W1964499056 cites W2007136633 @default.
• W1964499056 cites W2018516791 @default.
• W1964499056 cites W2022758760 @default.
• W1964499056 cites W2025649119 @default.
• W1964499056 cites W2025947566 @default.
• W1964499056 cites W2036237142 @default.
• W1964499056 cites W2038232367 @default.
• W1964499056 cites W2046635355 @default.
• W1964499056 cites W2052710445 @default.
• W1964499056 cites W2064353444 @default.
• W1964499056 cites W2069248257 @default.
• W1964499056 cites W2128056122 @default.
• W1964499056 cites W2146755607 @default.
• W1964499056 cites W3202352366 @default.
• W1964499056 cites W4247363344 @default.
• W1964499056 doi "https://doi.org/10.1016/s0002-9394(00)00882-5" @default.
• W1964499056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11292410" @default.
• W1964499056 hasPublicationYear "2001" @default.
• W1964499056 type Work @default.
• W1964499056 sameAs 1964499056 @default.
• W1964499056 citedByCount "204" @default.
• W1964499056 countsByYear W19644990562012 @default.
• W1964499056 countsByYear W19644990562013 @default.
• W1964499056 countsByYear W19644990562014 @default.
• W1964499056 countsByYear W19644990562015 @default.
• W1964499056 countsByYear W19644990562016 @default.
• W1964499056 countsByYear W19644990562017 @default.
• W1964499056 countsByYear W19644990562019 @default.
• W1964499056 countsByYear W19644990562020 @default.
• W1964499056 countsByYear W19644990562021 @default.
• W1964499056 countsByYear W19644990562023 @default.
• W1964499056 crossrefType "journal-article" @default.
• W1964499056 hasAuthorship W1964499056A5048478429 @default.
• W1964499056 hasAuthorship W1964499056A5082561940 @default.
• W1964499056 hasAuthorship W1964499056A5084778625 @default.
• W1964499056 hasAuthorship W1964499056A5090104091 @default.
• W1964499056 hasConcept C118487528 @default.
• W1964499056 hasConcept C126322002 @default.
• W1964499056 hasConcept C134018914 @default.
• W1964499056 hasConcept C141071460 @default.
• W1964499056 hasConcept C2777063560 @default.
• W1964499056 hasConcept C2778257484 @default.
• W1964499056 hasConcept C2778271429 @default.
• W1964499056 hasConcept C2778313320 @default.
• W1964499056 hasConcept C2778903070 @default.
• W1964499056 hasConcept C2779059073 @default.
• W1964499056 hasConcept C2779829184 @default.
• W1964499056 hasConcept C2780394083 @default.
• W1964499056 hasConcept C2780428090 @default.
• W1964499056 hasConcept C2780484280 @default.
• W1964499056 hasConcept C2780827179 @default.
• W1964499056 hasConcept C2781092963 @default.
• W1964499056 hasConcept C2781242345 @default.
• W1964499056 hasConcept C555293320 @default.
• W1964499056 hasConcept C71924100 @default.
• W1964499056 hasConceptScore W1964499056C118487528 @default.
• W1964499056 hasConceptScore W1964499056C126322002 @default.
• W1964499056 hasConceptScore W1964499056C134018914 @default.
• W1964499056 hasConceptScore W1964499056C141071460 @default.
• W1964499056 hasConceptScore W1964499056C2777063560 @default.
• W1964499056 hasConceptScore W1964499056C2778257484 @default.
• W1964499056 hasConceptScore W1964499056C2778271429 @default.
• W1964499056 hasConceptScore W1964499056C2778313320 @default.
• W1964499056 hasConceptScore W1964499056C2778903070 @default.
• W1964499056 hasConceptScore W1964499056C2779059073 @default.
• W1964499056 hasConceptScore W1964499056C2779829184 @default.
• W1964499056 hasConceptScore W1964499056C2780394083 @default.
• W1964499056 hasConceptScore W1964499056C2780428090 @default.
• W1964499056 hasConceptScore W1964499056C2780484280 @default.
• W1964499056 hasConceptScore W1964499056C2780827179 @default.
• W1964499056 hasConceptScore W1964499056C2781092963 @default.
• W1964499056 hasConceptScore W1964499056C2781242345 @default.
• W1964499056 hasConceptScore W1964499056C555293320 @default.
• W1964499056 hasConceptScore W1964499056C71924100 @default.
• W1964499056 hasIssue "4" @default.
• W1964499056 hasLocation W19644990561 @default.
• W1964499056 hasLocation W19644990562 @default.
• W1964499056 hasOpenAccess W1964499056 @default.
• W1964499056 hasPrimaryLocation W19644990561 @default.
• W1964499056 hasRelatedWork W1535800817 @default.
• W1964499056 hasRelatedWork W2005639104 @default.

• next